Do you want to read an article? Please log in or register.
Real-world performance of ATA risk estimates in predicting 1-year DTC outcomes: A prospective multicenter study of 2000 patients (ITCO Study #3)
Thyroid
Related content
COMMENTED
Type 2 Diabetes
Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol.
Heerspink HJL, Karasik A, Thuresson M, Melzer-Cohen C, Chodick G, Khunti K, Wilding JPH, Garcia Rodriguez LA, Cea-Soriano L, Kohsaka S, Nicolucci A, Lucisano G, Lin FJ, Wang CY, Wittbrodt E, Fenici P, Kosiborod M
doi: 10.1016/S2213-8587(19)30384-5.
Diabetes - GeneralType 2 DiabetesObesity and Bariatric Surgery
Clinical and Patient-Centered Outcomes in Obese Type 2 Diabetes Patients 3 Years After Randomization to Roux-en-Y Gastric Bypass Surgery Versus Intensive Lifestyle Management: The SLIMM-T2D Study
Diabetes Care.
Simonson DC, Halperin F, Foster K, Vernon A, Goldfine AB
doi: 10.2337/dc17-0487.
Type 2 Diabetes
Cardiovascular risk profiles: A cross-sectional study evaluating the generalisability of the glucagon-like peptide-1 receptor agonist cardiovascular outcome trials Rewind, Leader and Sustain-6 to the real-world type 2 diabetes population in the UK
Diabetes Obes Metab
Webb J, Mount J, von Arx LB, Rachman J, Spanopoulos D, Wood R, Tritton T, Massey O, Idris I
doi: 10.1111/dom.14580
COMMENTED
Type 1 Diabetes
A Patient-Level Model to Estimate Lifetime Health Outcomes of Patients With Type 1 Diabetes
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Care.
Tran-Duy A, Knight J, Palmer AJ, Petrie D, Lung TWC, Herman WH, Eliasson B, Svensson AM, Clarke PM
doi: 10.2337/dc19-2249.
Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study
Circ Cardiovasc Qual Outcomes.
Kaasenbrood L, Poulter NR, Sever PS, Colhoun HM, Livingstone SJ, Boekholdt SM, Pressel SL, Davis BR, van der Graaf Y, Visseren FL; CARDS, ALLHAT, and ASCOT Investigators
doi: 10.1161/
COMMENTED
Type 2 Diabetes
Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial - Cardiovascular Safety of Linagliptin vs. Glimepiride
Diabetes Care.
Patorno E, Schneeweiss S, Gopalakrishnan C, Martin D, Franklin JM
doi: 10.2337/dc19-0069.
Diabetes - GeneralType 2 Diabetes
Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study
Circulation.
Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, Jørgensen M, Thuresson M, Arya N, Bodegård J, Hammar N, Fenici P; CVD-REAL Investigators and Study Group
doi: 10.1161/CIRCULATIONAHA.
RECOMMENDED
Type 1 Diabetes
Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study
★ 1
Recommended by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Care.
Vantyghem MC, Chetboun M, Gmyr V, Jannin A, Espiard S, Le Mapihan K, Raverdy V, Delalleau N, Machuron F, Hubert T, Frimat M, Van Belle E, Hazzan M, Pigny P, Noel C, Caiazzo R, Kerr-Conte J, Pattou F
doi: 10.2337/dc19-0401.
COMMENTED
Type 1 DiabetesGlycemic Control
Evaluation of the SPECTRUM training programme for real-time continuous glucose monitoring: a real-world multicentre prospective study in 120 adults with type 1 diabetes
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabet Med
Schlüter S, Freckmann G, Heinemann L, Wintergerst P, Lange K
doi: 10.1111/dme.14467